Acceleration Provision. If the Company is subject to a Change in Control prior to the termination of the GP’s Vesting Period of the Initial Contribution or any additional increase of the Capital Contributions (as applicable), 100% of any restricted or unvested shares subject to this Agreement shall immediately vest.
Appears in 2 contracts
Sources: Operating Agreement (Biotech Co LLC), Operating Agreement (Bioceres Group PLC)